Need and opportunitywhat are the main security threats to the pharmaceuticals industry in Latin America?

Resumo

The high prices charged for patented pharmaceutical products have always been controversial in Latin America. Given the region’s ongoing economic disparities and history of underdevelopment, high prices have often served as barriers to access for essential medicines. On one hand, pharmaceutical manufacturers argue that high prices are necessary to support continued research and development and to generate a profitable return on investment. On the other hand, consumers, both private and public, argue that high prices have resulted in a historic, unmet need for affordable treatment options. Over the course of this debate, both sides have conducted a series of maneuvers and countermaneuvers that may have ultimately exposed some of the industry’s vulnerabilities. Through a series of analysis tools and interviews with industry professionals, this project examines vulnerabilities to determine risk while simultaneously attempting to answer the question: What are the main security threats to the pharmaceutical industry in Latin America? Justification for this project stems from the sharp increase in pharmaceuticalrelated crimes over the past decade that, in turn, have exposed patients to a greater number of risks, such as the risks of counterfeit and diverted products. An understanding of the main security threats is necessary in order to best mitigate risk, ensure product integrity and preserve public health.

Ficha do documento

Tipo

Dissertação

Ano

2013

Instituição

Fundação Getulio Vargas

Fonte

Repositório da FGV

Idioma

Inglês

Acesso

Acesso restrito

Identificador

oai:repositorio.fgv.br:10438/10848

Temas

Desenvolvimento EconômicoSaúde

Palavras-chave

SecurityThreatPharmaceuticalsSegurançaAmeaçaFarmacêuticosCiência políticaIndústria farmacêutica - América LatinaIndústria farmacêutica - Medidas de segurançaMedicamentos - PreçosSaúde pública - América Latina